A Randomized Controlled Trial Comparing HOPE Treatment and Present-Centered Therapy in Women Residing in Shelter with PTSD from Intimate Partner Violence.

category

rct

is Randomized Controlled Trial

true

basis

Urn randomization assigned 83 toHOPE and 89 toPCT+, stratifying substance-use diagnosis and medication status. Allocation-concealment implementation is not separately established from the report.

sources

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8294703/unicode

review Scope

full-text

scope

Paper

status

assessed

score

2

randomized Controlled Trial

true

peer Reviewed

true

blinding

not-confirmed

basis

Urn randomization assigned 83 toHOPE and 89 toPCT+, stratifying substance-use diagnosis and medication status. Allocation-concealment implementation is not separately established from the report.

sources

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8294703/unicode

review Scope

full-text

human Approval

false

display Crosses

2

masking Roles

participants

Author calls trial double-blind and describes all treatment as HOPE for blinding, identical workbook naming with arm-specific content, and discouraging sharing. These are allocation-identity concealment procedures; the participant role is not separately explicitly confirmed and masking success is unmeasured.

providers

Therapists trained in and delivered both distinct protocols; provider masking is not supported.

assessors

Graduate psychology assessors explicitly masked to treatment condition at follow-up.

analysts

Not established from accessed full report.

rating Scale

library-trust-factor/1-3

status

unassessed

score

Not recorded

evidence Type

Randomized active-comparator trial; author describes double-blind, but only assessor masking is explicitly role-verified

intervention

Empowerment-oriented, present-centered CBT with safety planning, cognitive restructuring and coping/relationship skills; current symptoms are linked to IPV but traumatic memories are not processed. Up to 16 sessions of 50–60 minutes during shelter and first 3 months after leaving; HOPE mean 8.86 sessions (SD 6.17), 44.2% attended at least 8. Eleven participants across arms received optional shelter boosters.

comparator

Attention-matched PCT+ with present-focused problem solving, psychoeducation and safety planning, up to 16 sessions; mean 10.06 (SD 5.82). Both groups also received standard shelter services.

sample

HOPE 83 versus PCT+ 89. ITT models use all available observations, not complete follow-up for 172. Follow-up counts 154, 142, 135, 127 at post-shelter, post-treatment, 6 and 12 months; outcome-specific denominators vary.

measurement

CAPS PTSD severity and IPV measures; Reliable PTSD improvement and diagnosis; Depression, empowerment, posttraumatic cognitions and health-related quality of life

timing

Post-shelter, post-treatment, 6 and 12 months; Post-treatment and later follow-up; Through 12 months post-treatment

trial Id

relationship Note

Explicit domestic/intimate-partner violence exposure in the studied population; psychological intervention is within Language scope. See limitation and quality fields; no population-wide clinical recommendation is implied.

measured Genes

None recorded

pathways

None recorded

source Access

level

full-text

source URLs

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8294703/unicode

retrieved At

2026-10-30T08:22:03.536155+00:00

outcomes

1. name

   CAPS PTSD severity and IPV measures

   follow Up

   Post-shelter, post-treatment, 6 and 12 months

   result

   Both active arms improved, but no significant between-group difference at any occasion or in change from baseline.

   effect Estimate

   Reported absolute between-group standardized differences≤0.32 at occasions and≤0.30 for change; no comparative confidence interval provided in the main-report results.

   uncertainty

   No inactive control; null superiority tests do not establish equivalence or isolate therapy from shelter/time effects.

   primary Status

   primary

2. name

   Reliable PTSD improvement and diagnosis

   follow Up

   Post-treatment and later follow-up

   result

   Post-treatment reliable CAPS improvement 54/65 (83.1%)HOPE versus 59/77 (76.6%)PCT+; group difference not significant. PTSD diagnosis rates also did not significantly differ at follow-up.

   effect Estimate

   Not recorded

   uncertainty

   These are assessed-participant denominators, not 172 randomized participants.

   primary Status

   Secondary clinical response analyses

3. name

   Depression, empowerment, posttraumatic cognitions and health-related quality of life

   follow Up

   Through 12 months post-treatment

   result

   Within-group improvements without significant comparative superiority.

   effect Estimate

   Not recorded

   uncertainty

   Some residual depression, subthreshold PTSD and abuse remained. Multiple comparisons used alpha<.01.

   primary Status

   secondary

quality

risk Of Bias

Randomization and masked clinical assessment strengthen comparison. Therapist allegiance/performance effects, possible contamination, unverified participant-role masking and follow-up attrition remain. No formal RoB or Jadad score assigned.

attrition

Assessment retention 154/172 post-shelter, 142/172 post-treatment, 135/172 at 6 months, 127/172 at 12 months. At 12 months 56/83 HOPE and 71/89 PCT+ contributed CAPS data. Treatment dropout 6/83 versus 5/89 is distinct from missing assessments. Black participants more often completed all assessments than White participants (81.6% vs 62.5%, p=.008).

confounding

ITT multivariate models use all available data under missing-at-random assumption; robust SEs and alpha<.01. Significant within-group change cannot separate psychotherapy, shelter services and time.

adverse Findings

Authors report no study-related serious adverse events, not zero adverse events overall. Ten participants were removed from assigned treatment for higher/different care: 6 HOPE, 4 PCT+; still invited to follow-up. Residual symptoms and some further abuse persisted.

transfer Limits

Women with recent IPV and diagnosed PTSD in US shelters; severe suicidal intent/plan, current psychosis, recent substance dependence, bipolar disorder or concurrent individual therapy were excluded.

jadad

not established

masking Roles

participants

Author calls trial double-blind and describes all treatment as HOPE for blinding, identical workbook naming with arm-specific content, and discouraging sharing. These are allocation-identity concealment procedures; the participant role is not separately explicitly confirmed and masking success is unmeasured.

providers

Therapists trained in and delivered both distinct protocols; provider masking is not supported.

assessors

Graduate psychology assessors explicitly masked to treatment condition at follow-up.

analysts

Not established from accessed full report.

population

relation

direct

population

Women residing in domestic-violence shelters with IPV-related PTSD.

exposure Evidence

At least one SVAW or PMWI IPV event in month before shelter entry and full DSM-IV-TR IPV-related PTSD by CAPS were required.

rationale

Explicit domestic/intimate-partner violence exposure in the studied population; psychological intervention is within Language scope.

transfer Limit

See limitation and quality fields; no population-wide clinical recommendation is implied.

count

Not recorded

source

Not recorded

retrieved At

Not recorded

status

not-assessed

language

Not recorded

status

approved-for-publication

approved By

Ben Korbel

approved At

2026-11-01

assessment

AI assessed; human approved for publication

scope

Qualified research-library summaries. No professional clinical peer review or treatment recommendation is claimed.

source Revision

audit-r2-33f9c465b9af

source Content Hash

33f9c465b9af21d2ad7753089729913b2fc0ecc265be6bf9f939e655c2a38d9d

level

full-text

source URLs

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8294703/unicode

retrieved At

2026-10-30T08:22:03.536155+00:00

auditor

Codex (AI)

completed At

2026-10-31T05:11:05.655793+00:00

prior Content Hash

163342d2c6a789b89d62f38350930deef22a8d0d44514e6e764c9a5da0376d8d

prior Revision

r1-163342d2c6a7

prior Source

frozen-120

source Verification

id

dv-adult-therapy-34305273

doi

10.1177/0361684320953120

pmid

34305273

fresh Metadata

Europe PMC core

metadata Retrieved

true

metadata SHA256

9ccd3e4a3e32e03627ab57e205aa8000b4efcf24722f1cb003403024e0b2cf9e

claim Check

Headline finding/design/limitations compared with indexed abstract or accessible primary evidence; retained methods amendments separately adjudicated.

sources

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120

applied Proposals

methods-adult/proposed-candidates.json

method

AI editorial assessment of all 130 publication records: compare identity, headline finding, design, relevance and limitations with indexed abstracts or available primary material; adjudicate retained source-supported methods amendments. This is a source-limited publication audit, not an independent full-text systematic review or a clinical guideline.

limitations

Abstract-only records do not establish allocation concealment, complete harms reporting or full risk of bias. · No formal independent RoB 2, GRADE appraisal or numerical reconstruction of every effect was performed. · Source-access labels describe retained appraisal evidence; fuller prior appraisals were checked through their source ledgers and selected material, not independently repeated in full. · Publication counts are not independent trial or participant counts; cohort links and overlapping review evidence remain provisional. · A randomized design cross does not indicate benefit, low risk of bias or human approval. No double-blind trial is verified in this release. · No professional clinical peer review is claimed. Recommended content is limited to accurately qualified research summaries.

https://doi.org/10.1177/0361684320953120 · https://pubmed.ncbi.nlm.nih.gov/34305273/ · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8294703/unicode

language

Clinical & self-report

count

Not recorded

source

Not recorded

retrieved At

Not recorded

status

not-assessed

category

rct

is Randomized Controlled Trial

true

basis

Urn randomization assigned 83 toHOPE and 89 toPCT+, stratifying substance-use diagnosis and medication status. Allocation-concealment implementation is not separately established from the report.

sources

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8294703/unicode

review Scope

full-text

scope

Paper

status

assessed

score

2

randomized Controlled Trial

true

peer Reviewed

true

blinding

not-confirmed

basis

Urn randomization assigned 83 toHOPE and 89 toPCT+, stratifying substance-use diagnosis and medication status. Allocation-concealment implementation is not separately established from the report.

sources

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8294703/unicode

review Scope

full-text

human Approval

false

display Crosses

2

masking Roles

participants

Author calls trial double-blind and describes all treatment as HOPE for blinding, identical workbook naming with arm-specific content, and discouraging sharing. These are allocation-identity concealment procedures; the participant role is not separately explicitly confirmed and masking success is unmeasured.

providers

Therapists trained in and delivered both distinct protocols; provider masking is not supported.

assessors

Graduate psychology assessors explicitly masked to treatment condition at follow-up.

analysts

Not established from accessed full report.

rating Scale

library-trust-factor/1-3

language

Not recorded

1. key

   language:domestic-family-violence

   title

   Domestic & Family Violence

   collection

   language

   trust Score

   2

1. id

   language-dv-dv-adult-therapy-34305273

   aliases

   None recorded

   title

   A Randomized Controlled Trial Comparing HOPE Treatment and Present-Centered Therapy in Women Residing in Shelter with PTSD from Intimate Partner Violence.

   authors

   Johnson DM; Palmieri PA; Zlotnick C; Johnson NL; Hoffman L; Holmes SC; Ceroni TL

   year

   2020

   journal

   Psychology of women quarterly

   doi

   10.1177/0361684320953120

   pmid

   34305273

   urls

   https://doi.org/10.1177/0361684320953120 · https://pubmed.ncbi.nlm.nih.gov/34305273/ · https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8294703/unicode

   collections

   language

   categories

   Clinical & self-report

   targets

   None recorded

   neurotransmitters

   None recorded

   conditions

   ptsd · trauma · depression

   condition Evidence

   1. id

      ptsd

      evidence

      1. field

         title

         text

         A Randomized Controlled Trial Comparing HOPE Treatment and Present-Centered Therapy in Women Residing in Shelter with PTSD from Intimate Partner Violence.

         matched Text

         PTSD

      2. field

         population

         text

         Women residing in domestic-violence shelters with IPV-related PTSD.

         matched Text

         PTSD

      3. field

         outcomes

         text

         CAPS PTSD severity and IPV measures | Reliable PTSD improvement and diagnosis | Depression, empowerment, posttraumatic cognitions and health-related quality of life

         matched Text

         PTSD

      scope

      Study population or investigated outcome; not a diagnosis or efficacy claim.

   2. id

      trauma

      evidence

      1. field

         outcomes

         text

         CAPS PTSD severity and IPV measures | Reliable PTSD improvement and diagnosis | Depression, empowerment, posttraumatic cognitions and health-related quality of life

         matched Text

         posttraumatic

      scope

      Study population or investigated outcome; not a diagnosis or efficacy claim.

   3. id

      depression

      evidence

      1. field

         outcomes

         text

         CAPS PTSD severity and IPV measures | Reliable PTSD improvement and diagnosis | Depression, empowerment, posttraumatic cognitions and health-related quality of life

         matched Text

         Depression

      scope

      Study population or investigated outcome; not a diagnosis or efficacy claim.

   age Groups

   adults

   age Population

   record Id

   dv-adult-therapy-34305273

   collections

   language

   groups

   adults

   reported Ages

   Observed age 19–59 years; mean 35.13 (SD 9.12).

   youth Scope

   Not recorded

   youth Source Note

   No child or adolescent participants in reported sample.

   source URL

   https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core

   basis Type

   source-limited-ai-editorial-assessment

   classification Note

   Original age terms: adults. Programme targets or possible eligibility are not counted as observed ages.

   community Matches

   1. category Id

      domestic-violence

      relation

      direct

   kind

   Journal article

   design

   Randomized active-comparator trial; author describes double-blind, but only assessor masking is explicitly role-verified

   origin

   approved-dv-20261101

   priority

   1

   quotes

   None recorded

   finding

   HOPE did not outperform an attention-matched PCT+ intervention on PTSD, IPV or secondary outcomes. Both active groups improved; no untreated control supports an absolute treatment-effect estimate.

   summary

   HOPE did not outperform an attention-matched PCT+ intervention on PTSD, IPV or secondary outcomes. Both active groups improved; no untreated control supports an absolute treatment-effect estimate.

   limitation

   Treatment providers knew protocols, and shared shelters permit contamination. Participant masking identity is not explicitly role-confirmed despite double-blind labeling. Missing-at-random models assume an unproven missingness mechanism; only 127/172 remained at 12 months. Active-comparator null results are not equivalence evidence.

   evidence

   evidence Type

   Randomized active-comparator trial; author describes double-blind, but only assessor masking is explicitly role-verified

   intervention

   Empowerment-oriented, present-centered CBT with safety planning, cognitive restructuring and coping/relationship skills; current symptoms are linked to IPV but traumatic memories are not processed. Up to 16 sessions of 50–60 minutes during shelter and first 3 months after leaving; HOPE mean 8.86 sessions (SD 6.17), 44.2% attended at least 8. Eleven participants across arms received optional shelter boosters.

   comparator

   Attention-matched PCT+ with present-focused problem solving, psychoeducation and safety planning, up to 16 sessions; mean 10.06 (SD 5.82). Both groups also received standard shelter services.

   sample

   HOPE 83 versus PCT+ 89. ITT models use all available observations, not complete follow-up for 172. Follow-up counts 154, 142, 135, 127 at post-shelter, post-treatment, 6 and 12 months; outcome-specific denominators vary.

   measurement

   CAPS PTSD severity and IPV measures; Reliable PTSD improvement and diagnosis; Depression, empowerment, posttraumatic cognitions and health-related quality of life

   timing

   Post-shelter, post-treatment, 6 and 12 months; Post-treatment and later follow-up; Through 12 months post-treatment

   trial Id

   relationship Note

   Explicit domestic/intimate-partner violence exposure in the studied population; psychological intervention is within Language scope. See limitation and quality fields; no population-wide clinical recommendation is implied.

   measured Genes

   None recorded

   pathways

   None recorded

   source Access

   level

   full-text

   source URLs

   https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8294703/unicode

   retrieved At

   2026-10-30T08:22:03.536155+00:00

   outcomes

   1. name

      CAPS PTSD severity and IPV measures

      follow Up

      Post-shelter, post-treatment, 6 and 12 months

      result

      Both active arms improved, but no significant between-group difference at any occasion or in change from baseline.

      effect Estimate

      Reported absolute between-group standardized differences≤0.32 at occasions and≤0.30 for change; no comparative confidence interval provided in the main-report results.

      uncertainty

      No inactive control; null superiority tests do not establish equivalence or isolate therapy from shelter/time effects.

      primary Status

      primary

   2. name

      Reliable PTSD improvement and diagnosis

      follow Up

      Post-treatment and later follow-up

      result

      Post-treatment reliable CAPS improvement 54/65 (83.1%)HOPE versus 59/77 (76.6%)PCT+; group difference not significant. PTSD diagnosis rates also did not significantly differ at follow-up.

      effect Estimate

      Not recorded

      uncertainty

      These are assessed-participant denominators, not 172 randomized participants.

      primary Status

      Secondary clinical response analyses

   3. name

      Depression, empowerment, posttraumatic cognitions and health-related quality of life

      follow Up

      Through 12 months post-treatment

      result

      Within-group improvements without significant comparative superiority.

      effect Estimate

      Not recorded

      uncertainty

      Some residual depression, subthreshold PTSD and abuse remained. Multiple comparisons used alpha<.01.

      primary Status

      secondary

   quality

   risk Of Bias

   Randomization and masked clinical assessment strengthen comparison. Therapist allegiance/performance effects, possible contamination, unverified participant-role masking and follow-up attrition remain. No formal RoB or Jadad score assigned.

   attrition

   Assessment retention 154/172 post-shelter, 142/172 post-treatment, 135/172 at 6 months, 127/172 at 12 months. At 12 months 56/83 HOPE and 71/89 PCT+ contributed CAPS data. Treatment dropout 6/83 versus 5/89 is distinct from missing assessments. Black participants more often completed all assessments than White participants (81.6% vs 62.5%, p=.008).

   confounding

   ITT multivariate models use all available data under missing-at-random assumption; robust SEs and alpha<.01. Significant within-group change cannot separate psychotherapy, shelter services and time.

   adverse Findings

   Authors report no study-related serious adverse events, not zero adverse events overall. Ten participants were removed from assigned treatment for higher/different care: 6 HOPE, 4 PCT+; still invited to follow-up. Residual symptoms and some further abuse persisted.

   transfer Limits

   Women with recent IPV and diagnosed PTSD in US shelters; severe suicidal intent/plan, current psychosis, recent substance dependence, bipolar disorder or concurrent individual therapy were excluded.

   jadad

   not established

   masking Roles

   participants

   Author calls trial double-blind and describes all treatment as HOPE for blinding, identical workbook naming with arm-specific content, and discouraging sharing. These are allocation-identity concealment procedures; the participant role is not separately explicitly confirmed and masking success is unmeasured.

   providers

   Therapists trained in and delivered both distinct protocols; provider masking is not supported.

   assessors

   Graduate psychology assessors explicitly masked to treatment condition at follow-up.

   analysts

   Not established from accessed full report.

   population

   relation

   direct

   population

   Women residing in domestic-violence shelters with IPV-related PTSD.

   exposure Evidence

   At least one SVAW or PMWI IPV event in month before shelter entry and full DSM-IV-TR IPV-related PTSD by CAPS were required.

   rationale

   Explicit domestic/intimate-partner violence exposure in the studied population; psychological intervention is within Language scope.

   transfer Limit

   See limitation and quality fields; no population-wide clinical recommendation is implied.

   study Design Assessment

   category

   rct

   is Randomized Controlled Trial

   true

   basis

   Urn randomization assigned 83 toHOPE and 89 toPCT+, stratifying substance-use diagnosis and medication status. Allocation-concealment implementation is not separately established from the report.

   sources

   https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8294703/unicode

   review Scope

   full-text

   paper Trust Assessment

   scope

   Paper

   status

   assessed

   score

   2

   randomized Controlled Trial

   true

   peer Reviewed

   true

   blinding

   not-confirmed

   basis

   Urn randomization assigned 83 toHOPE and 89 toPCT+, stratifying substance-use diagnosis and medication status. Allocation-concealment implementation is not separately established from the report.

   sources

   https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8294703/unicode

   review Scope

   full-text

   human Approval

   false

   display Crosses

   2

   masking Roles

   participants

   Author calls trial double-blind and describes all treatment as HOPE for blinding, identical workbook naming with arm-specific content, and discouraging sharing. These are allocation-identity concealment procedures; the participant role is not separately explicitly confirmed and masking success is unmeasured.

   providers

   Therapists trained in and delivered both distinct protocols; provider masking is not supported.

   assessors

   Graduate psychology assessors explicitly masked to treatment condition at follow-up.

   analysts

   Not established from accessed full report.

   rating Scale

   library-trust-factor/1-3

   jadad

   status

   unassessed

   score

   Not recorded

   citation Snapshot

   count

   Not recorded

   source

   Not recorded

   retrieved At

   Not recorded

   status

   not-assessed

   citation Count

   Not recorded

   publication Approval

   status

   approved-for-publication

   approved By

   Ben Korbel

   approved At

   2026-11-01

   assessment

   AI assessed; human approved for publication

   scope

   Qualified research-library summaries. No professional clinical peer review or treatment recommendation is claimed.

   source Revision

   audit-r2-33f9c465b9af

   source Content Hash

   33f9c465b9af21d2ad7753089729913b2fc0ecc265be6bf9f939e655c2a38d9d

   source Access

   level

   full-text

   source URLs

   https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8294703/unicode

   retrieved At

   2026-10-30T08:22:03.536155+00:00

   study Family Id

   HOPE-PCT-172-2020

   family Linkage Uncertain

   false

   approaches

   None recorded

   record Id

   dv-adult-therapy-34305273

   source Pages

   None recorded

   editorial Audit

   auditor

   Codex (AI)

   completed At

   2026-10-31T05:11:05.655793+00:00

   prior Content Hash

   163342d2c6a789b89d62f38350930deef22a8d0d44514e6e764c9a5da0376d8d

   prior Revision

   r1-163342d2c6a7

   prior Source

   frozen-120

   source Verification

   id

   dv-adult-therapy-34305273

   doi

   10.1177/0361684320953120

   pmid

   34305273

   fresh Metadata

   Europe PMC core

   metadata Retrieved

   true

   metadata SHA256

   9ccd3e4a3e32e03627ab57e205aa8000b4efcf24722f1cb003403024e0b2cf9e

   claim Check

   Headline finding/design/limitations compared with indexed abstract or accessible primary evidence; retained methods amendments separately adjudicated.

   sources

   https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120

   applied Proposals

   methods-adult/proposed-candidates.json

   method

   AI editorial assessment of all 130 publication records: compare identity, headline finding, design, relevance and limitations with indexed abstracts or available primary material; adjudicate retained source-supported methods amendments. This is a source-limited publication audit, not an independent full-text systematic review or a clinical guideline.

   limitations

   Abstract-only records do not establish allocation concealment, complete harms reporting or full risk of bias. · No formal independent RoB 2, GRADE appraisal or numerical reconstruction of every effect was performed. · Source-access labels describe retained appraisal evidence; fuller prior appraisals were checked through their source ledgers and selected material, not independently repeated in full. · Publication counts are not independent trial or participant counts; cohort links and overlapping review evidence remain provisional. · A randomized design cross does not indicate benefit, low risk of bias or human approval. No double-blind trial is verified in this release. · No professional clinical peer review is claimed. Recommended content is limited to accurately qualified research summaries.

   assessment Record

   id

   dv-adult-therapy-34305273

   title

   A Randomized Controlled Trial Comparing HOPE Treatment and Present-Centered Therapy in Women Residing in Shelter with PTSD from Intimate Partner Violence.

   authors

   Johnson DM · Palmieri PA · Zlotnick C · Johnson NL · Hoffman L · Holmes SC · Ceroni TL

   year

   2020

   journal

   Psychology of women quarterly

   doi

   10.1177/0361684320953120

   pmid

   34305273

   trial Registration

   None recorded

   collection

   language

   intervention Family

   HOPE: empowerment-oriented cognitive-behavioral treatment.

   publication Type

   Primary intervention study

   study Family Id

   HOPE-PCT-172-2020

   family Linkage Uncertain

   false

   existing Repository Matches

   None recorded

   relevance

   relation

   direct

   population

   Women residing in domestic-violence shelters with IPV-related PTSD.

   exposure Evidence

   At least one SVAW or PMWI IPV event in month before shelter entry and full DSM-IV-TR IPV-related PTSD by CAPS were required.

   rationale

   Explicit domestic/intimate-partner violence exposure in the studied population; psychological intervention is within Language scope.

   transfer Limit

   See limitation and quality fields; no population-wide clinical recommendation is implied.

   age

   groups

   adults

   reported Range

   Observed age 19–59 years; mean 35.13 (SD 9.12).

   youth Scope

   No child or adolescent participants in reported sample.

   country

   United States

   setting

   Six domestic-violence shelters in five Midwestern US counties; data collected February 2013–February 2017.

   sample Size

   randomized

   172

   analyzed

   172

   description

   HOPE 83 versus PCT+ 89. ITT models use all available observations, not complete follow-up for 172. Follow-up counts 154, 142, 135, 127 at post-shelter, post-treatment, 6 and 12 months; outcome-specific denominators vary.

   intervention

   description

   Empowerment-oriented, present-centered CBT with safety planning, cognitive restructuring and coping/relationship skills; current symptoms are linked to IPV but traumatic memories are not processed.

   dose

   Up to 16 sessions of 50–60 minutes during shelter and first 3 months after leaving; HOPE mean 8.86 sessions (SD 6.17), 44.2% attended at least 8. Eleven participants across arms received optional shelter boosters.

   provider

   Four masters-level therapists trained in both protocols, practice cases and continuing supervision; external sampled fidelity ratings.

   comparator

   Attention-matched PCT+ with present-focused problem solving, psychoeducation and safety planning, up to 16 sessions; mean 10.06 (SD 5.82). Both groups also received standard shelter services.

   outcomes

   1. name

      CAPS PTSD severity and IPV measures

      follow Up

      Post-shelter, post-treatment, 6 and 12 months

      result

      Both active arms improved, but no significant between-group difference at any occasion or in change from baseline.

      effect Estimate

      Reported absolute between-group standardized differences≤0.32 at occasions and≤0.30 for change; no comparative confidence interval provided in the main-report results.

      uncertainty

      No inactive control; null superiority tests do not establish equivalence or isolate therapy from shelter/time effects.

      primary Status

      primary

   2. name

      Reliable PTSD improvement and diagnosis

      follow Up

      Post-treatment and later follow-up

      result

      Post-treatment reliable CAPS improvement 54/65 (83.1%)HOPE versus 59/77 (76.6%)PCT+; group difference not significant. PTSD diagnosis rates also did not significantly differ at follow-up.

      effect Estimate

      Not recorded

      uncertainty

      These are assessed-participant denominators, not 172 randomized participants.

      primary Status

      Secondary clinical response analyses

   3. name

      Depression, empowerment, posttraumatic cognitions and health-related quality of life

      follow Up

      Through 12 months post-treatment

      result

      Within-group improvements without significant comparative superiority.

      effect Estimate

      Not recorded

      uncertainty

      Some residual depression, subthreshold PTSD and abuse remained. Multiple comparisons used alpha<.01.

      primary Status

      secondary

   finding

   HOPE did not outperform an attention-matched PCT+ intervention on PTSD, IPV or secondary outcomes. Both active groups improved; no untreated control supports an absolute treatment-effect estimate.

   limitation

   Treatment providers knew protocols, and shared shelters permit contamination. Participant masking identity is not explicitly role-confirmed despite double-blind labeling. Missing-at-random models assume an unproven missingness mechanism; only 127/172 remained at 12 months. Active-comparator null results are not equivalence evidence.

   design

   type

   Randomized active-comparator trial; author describes double-blind, but only assessor masking is explicitly role-verified

   randomization Evidence

   Urn randomization assigned 83 toHOPE and 89 toPCT+, stratifying substance-use diagnosis and medication status. Allocation-concealment implementation is not separately established from the report.

   masking

   participants

   Author calls trial double-blind and describes all treatment as HOPE for blinding, identical workbook naming with arm-specific content, and discouraging sharing. These are allocation-identity concealment procedures; the participant role is not separately explicitly confirmed and masking success is unmeasured.

   providers

   Therapists trained in and delivered both distinct protocols; provider masking is not supported.

   assessors

   Graduate psychology assessors explicitly masked to treatment condition at follow-up.

   analysts

   Not established from accessed full report.

   crosses

   1

   cross Rationale

   Retain one cross: randomization and assessor masking verified. Reported double-blind label plus common naming does not independently verify the participant masking role. A two-cross proposal requires further role-specific primary confirmation; successful masking measurement is a separate limitation.

   quality

   risk Of Bias

   Randomization and masked clinical assessment strengthen comparison. Therapist allegiance/performance effects, possible contamination, unverified participant-role masking and follow-up attrition remain. No formal RoB or Jadad score assigned.

   attrition

   Assessment retention 154/172 post-shelter, 142/172 post-treatment, 135/172 at 6 months, 127/172 at 12 months. At 12 months 56/83 HOPE and 71/89 PCT+ contributed CAPS data. Treatment dropout 6/83 versus 5/89 is distinct from missing assessments. Black participants more often completed all assessments than White participants (81.6% vs 62.5%, p=.008).

   confounding

   ITT multivariate models use all available data under missing-at-random assumption; robust SEs and alpha<.01. Significant within-group change cannot separate psychotherapy, shelter services and time.

   adverse Findings

   Authors report no study-related serious adverse events, not zero adverse events overall. Ten participants were removed from assigned treatment for higher/different care: 6 HOPE, 4 PCT+; still invited to follow-up. Residual symptoms and some further abuse persisted.

   transfer Limits

   Women with recent IPV and diagnosed PTSD in US shelters; severe suicidal intent/plan, current psychosis, recent substance dependence, bipolar disorder or concurrent individual therapy were excluded.

   jadad

   not established

   access

   level

   full-text

   source URLs

   https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8294703/unicode

   retrieved At

   2026-10-30T08:22:03.536155+00:00

   sources

   1. url

      https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core

      type

      Europe PMC core record sourced from PubMed/MEDLINE

      retrieved At

      2026-10-30T07:14:57.490108+00:00

      identity Verified

      true

      notes

      Primary-publication abstract and bibliographic metadata accessed; canonical PubMed record: https://pubmed.ncbi.nlm.nih.gov/34305273/

      retrieval Query URL

      https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=%28%22domestic+violence%22+OR+%22intimate+partner+violence%22%29+AND+%28Crespo+OR+Echeburua+OR+Kubany+OR+Zlotnick+OR+Hegarty+OR+Ferrari%29&format=json&resultType=core&pageSize=200

   2. url

      https://api.crossref.org/works/10.1177%2F0361684320953120

      type

      Crossref DOI registration metadata

      retrieved At

      2026-10-30T07:19:57.441368+00:00

      identity Verified

      true

      notes

      DOI identity cross-check; metadata title: A Randomized Controlled Trial Comparing HOPE Treatment and Present-Centered Therapy in Women Residing in Shelter With PTSD From Intimate Partner Violence. Correction/update relations checked.

   3. url

      https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8294703/unicode

      type

      primary-full-text

      retrieved At

      2026-10-30T08:22:03.536155+00:00

      identity Verified

      true

      notes

      Full primary report methods, results, tables and discussion inspected.

   publication Status

   status

   ppublish

   correction Retraction Check

   europe PMCpub Types

   research-article · Journal Article

   crossref Update Relations

   None recorded

   crossref Relations

   crossref Checked

   true

   uncertainty

   No comprehensive publisher/Crossmark or registry audit claimed; correction/retraction absence is limited to accessed metadata.

   recommendation Rationale

   Retain as pending candidate evidence; interpret the study design, null outcomes and access limits together.

   review

   status

   pending

   reviewer

   Not recorded

   assessment Status

   assessed

   assessment Notes

   Full primary report methods, results, tables and discussion inspected. · This proposal is not human approval. It revises an existing publication without increasing screened, publication or study-family totals. · Cohort collected 2013–2017 is distinct from the earlier HOPE 70 and HOPE 60 trials; common intervention name does not imply repeated participants. Preserve HOPE-PCT-172-2020 family identifier. · Main manuscript and Tables 2–4 inspected via official NLM BioC author-manuscript API; supplementary statistical syntax and trial registry not independently verified.

   review Ready

   true

   review Readiness

   ai-editorial-audit-complete-release-pending

   research Lane

   adult-therapy

   later Review Evidence

   id

   dv-adult-therapy-34305273

   title

   A Randomized Controlled Trial Comparing HOPE Treatment and Present-Centered Therapy in Women Residing in Shelter with PTSD from Intimate Partner Violence.

   prior Revision

   r1-163342d2c6a7

   prior Content Hash

   163342d2c6a789b89d62f38350930deef22a8d0d44514e6e764c9a5da0376d8d

   original

   review Ready

   true

   review Readiness

   ready-with-access-limits

   finding

   Both active treatments showed substantial PTSD improvement and smaller improvements in violence, depression, empowerment and quality of life. The abstract does not establish HOPE superiority.

   limitation

   Both groups received active treatment; within-group improvement does not establish superiority or benefit against no treatment. Full methods and adverse-event reporting remain to be assessed.

   adverse Findings

   Adverse-event reporting not established from accessed source; absence of reporting is not evidence of no harm.

   crosses

   1

   access

   abstract

   action

   supplement

   hold Current Revision

   false

   cross Verification On Hold

   false

   new Evidence

   Full methods/results confirm no significant between-group outcome differences. At 12 months 127/172 were retained; ten needed different or higher care. The report states no study-related serious adverse events. Assessors were masked; participant masking is insufficiently explicit for two crosses.

   revised Interpretation

   The frozen no-superiority interpretation remains appropriate. Narrow the adverse-event wording, add attrition, and retain one cross pending role-specific masking adjudication.

   required Before Approval

   No new hold on the conservative core finding. Review supplementary details in a new revision; do not award two crosses from the author’s double-blind label alone.

   source URLs

   https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8294703/unicode

   source Location

   Methods; retention/safety/results; Tables 2–4

   assessment Changed

   false

   human Approval

   false

   publication Recommendation

   status

   recommended-summary

   reason

   Suitable as a qualified research-library summary at the stated source-access level. This is not a conclusion that the intervention is effective or safe.

   scope

   Research summary only; no treatment recommendation

   human Release Approval

   false

   editorial Audit

   auditor

   Codex (AI)

   completed At

   2026-10-31T05:11:05.655793+00:00

   prior Content Hash

   163342d2c6a789b89d62f38350930deef22a8d0d44514e6e764c9a5da0376d8d

   prior Revision

   r1-163342d2c6a7

   prior Source

   frozen-120

   source Verification

   id

   dv-adult-therapy-34305273

   doi

   10.1177/0361684320953120

   pmid

   34305273

   fresh Metadata

   Europe PMC core

   metadata Retrieved

   true

   metadata SHA256

   9ccd3e4a3e32e03627ab57e205aa8000b4efcf24722f1cb003403024e0b2cf9e

   claim Check

   Headline finding/design/limitations compared with indexed abstract or accessible primary evidence; retained methods amendments separately adjudicated.

   sources

   https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120

   applied Proposals

   methods-adult/proposed-candidates.json

   method

   AI editorial assessment of all 130 publication records: compare identity, headline finding, design, relevance and limitations with indexed abstracts or available primary material; adjudicate retained source-supported methods amendments. This is a source-limited publication audit, not an independent full-text systematic review or a clinical guideline.

   limitations

   Abstract-only records do not establish allocation concealment, complete harms reporting or full risk of bias. · No formal independent RoB 2, GRADE appraisal or numerical reconstruction of every effect was performed. · Source-access labels describe retained appraisal evidence; fuller prior appraisals were checked through their source ledgers and selected material, not independently repeated in full. · Publication counts are not independent trial or participant counts; cohort links and overlapping review evidence remain provisional. · A randomized design cross does not indicate benefit, low risk of bias or human approval. No double-blind trial is verified in this release. · No professional clinical peer review is claimed. Recommended content is limited to accurately qualified research summaries.

   study Design Assessment

   category

   rct

   is Randomized Controlled Trial

   true

   basis

   Urn randomization assigned 83 toHOPE and 89 toPCT+, stratifying substance-use diagnosis and medication status. Allocation-concealment implementation is not separately established from the report.

   sources

   https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8294703/unicode

   review Scope

   full-text

   paper Trust Assessment

   scope

   Paper

   status

   assessed

   score

   2

   randomized Controlled Trial

   true

   peer Reviewed

   true

   blinding

   not-confirmed

   basis

   Retain one cross: randomization and assessor masking verified. Reported double-blind label plus common naming does not independently verify the participant masking role. A two-cross proposal requires further role-specific primary confirmation; successful masking measurement is a separate limitation.

   sources

   https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8294703/unicode

   review Scope

   full-text

   human Approval

   false

   display Crosses

   1

   masking Roles

   participants

   Author calls trial double-blind and describes all treatment as HOPE for blinding, identical workbook naming with arm-specific content, and discouraging sharing. These are allocation-identity concealment procedures; the participant role is not separately explicitly confirmed and masking success is unmeasured.

   providers

   Therapists trained in and delivered both distinct protocols; provider masking is not supported.

   assessors

   Graduate psychology assessors explicitly masked to treatment condition at follow-up.

   analysts

   Not established from accessed full report.

   jadad

   status

   unassessed

   score

   Not recorded

   evidence

   population

   relation

   direct

   population

   Women residing in domestic-violence shelters with IPV-related PTSD.

   exposure Evidence

   At least one SVAW or PMWI IPV event in month before shelter entry and full DSM-IV-TR IPV-related PTSD by CAPS were required.

   rationale

   Explicit domestic/intimate-partner violence exposure in the studied population; psychological intervention is within Language scope.

   transfer Limit

   See limitation and quality fields; no population-wide clinical recommendation is implied.

   intervention

   description

   Empowerment-oriented, present-centered CBT with safety planning, cognitive restructuring and coping/relationship skills; current symptoms are linked to IPV but traumatic memories are not processed.

   dose

   Up to 16 sessions of 50–60 minutes during shelter and first 3 months after leaving; HOPE mean 8.86 sessions (SD 6.17), 44.2% attended at least 8. Eleven participants across arms received optional shelter boosters.

   provider

   Four masters-level therapists trained in both protocols, practice cases and continuing supervision; external sampled fidelity ratings.

   comparator

   Attention-matched PCT+ with present-focused problem solving, psychoeducation and safety planning, up to 16 sessions; mean 10.06 (SD 5.82). Both groups also received standard shelter services.

   outcomes

   1. name

      CAPS PTSD severity and IPV measures

      follow Up

      Post-shelter, post-treatment, 6 and 12 months

      result

      Both active arms improved, but no significant between-group difference at any occasion or in change from baseline.

      effect Estimate

      Reported absolute between-group standardized differences≤0.32 at occasions and≤0.30 for change; no comparative confidence interval provided in the main-report results.

      uncertainty

      No inactive control; null superiority tests do not establish equivalence or isolate therapy from shelter/time effects.

      primary Status

      primary

   2. name

      Reliable PTSD improvement and diagnosis

      follow Up

      Post-treatment and later follow-up

      result

      Post-treatment reliable CAPS improvement 54/65 (83.1%)HOPE versus 59/77 (76.6%)PCT+; group difference not significant. PTSD diagnosis rates also did not significantly differ at follow-up.

      effect Estimate

      Not recorded

      uncertainty

      These are assessed-participant denominators, not 172 randomized participants.

      primary Status

      Secondary clinical response analyses

   3. name

      Depression, empowerment, posttraumatic cognitions and health-related quality of life

      follow Up

      Through 12 months post-treatment

      result

      Within-group improvements without significant comparative superiority.

      effect Estimate

      Not recorded

      uncertainty

      Some residual depression, subthreshold PTSD and abuse remained. Multiple comparisons used alpha<.01.

      primary Status

      secondary

   access

   level

   full-text

   source URLs

   https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8294703/unicode

   retrieved At

   2026-10-30T08:22:03.536155+00:00

   citation Snapshot

   count

   Not recorded

   source

   Not recorded

   retrieved At

   Not recorded

   status

   not-assessed

   provenance

   Discovered by AI

   content Hash

   33f9c465b9af21d2ad7753089729913b2fc0ecc265be6bf9f939e655c2a38d9d

   revision

   audit-r2-33f9c465b9af

   archive Entries

   None recorded

   collection

   language

   chapter Number

   5

   topic Id

   domestic-family-violence

   topic Title

   Domestic & Family Violence

   trust Score

   2

evidence Type

Randomized active-comparator trial; author describes double-blind, but only assessor masking is explicitly role-verified

intervention

Empowerment-oriented, present-centered CBT with safety planning, cognitive restructuring and coping/relationship skills; current symptoms are linked to IPV but traumatic memories are not processed. Up to 16 sessions of 50–60 minutes during shelter and first 3 months after leaving; HOPE mean 8.86 sessions (SD 6.17), 44.2% attended at least 8. Eleven participants across arms received optional shelter boosters.

comparator

Attention-matched PCT+ with present-focused problem solving, psychoeducation and safety planning, up to 16 sessions; mean 10.06 (SD 5.82). Both groups also received standard shelter services.

sample

HOPE 83 versus PCT+ 89. ITT models use all available observations, not complete follow-up for 172. Follow-up counts 154, 142, 135, 127 at post-shelter, post-treatment, 6 and 12 months; outcome-specific denominators vary.

measurement

CAPS PTSD severity and IPV measures; Reliable PTSD improvement and diagnosis; Depression, empowerment, posttraumatic cognitions and health-related quality of life

timing

Post-shelter, post-treatment, 6 and 12 months; Post-treatment and later follow-up; Through 12 months post-treatment

trial Id

relationship Note

Explicit domestic/intimate-partner violence exposure in the studied population; psychological intervention is within Language scope. See limitation and quality fields; no population-wide clinical recommendation is implied.

measured Genes

None recorded

pathways

None recorded

source Access

level

full-text

source URLs

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:34305273%20AND%20SRC:MED&format=json&resultType=core · https://api.crossref.org/works/10.1177%2F0361684320953120 · https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC8294703/unicode

retrieved At

2026-10-30T08:22:03.536155+00:00

outcomes

1. name

   CAPS PTSD severity and IPV measures

   follow Up

   Post-shelter, post-treatment, 6 and 12 months

   result

   Both active arms improved, but no significant between-group difference at any occasion or in change from baseline.

   effect Estimate

   Reported absolute between-group standardized differences≤0.32 at occasions and≤0.30 for change; no comparative confidence interval provided in the main-report results.

   uncertainty

   No inactive control; null superiority tests do not establish equivalence or isolate therapy from shelter/time effects.

   primary Status

   primary

2. name

   Reliable PTSD improvement and diagnosis

   follow Up

   Post-treatment and later follow-up

   result

   Post-treatment reliable CAPS improvement 54/65 (83.1%)HOPE versus 59/77 (76.6%)PCT+; group difference not significant. PTSD diagnosis rates also did not significantly differ at follow-up.

   effect Estimate

   Not recorded

   uncertainty

   These are assessed-participant denominators, not 172 randomized participants.

   primary Status

   Secondary clinical response analyses

3. name

   Depression, empowerment, posttraumatic cognitions and health-related quality of life

   follow Up

   Through 12 months post-treatment

   result

   Within-group improvements without significant comparative superiority.

   effect Estimate

   Not recorded

   uncertainty

   Some residual depression, subthreshold PTSD and abuse remained. Multiple comparisons used alpha<.01.

   primary Status

   secondary

quality

risk Of Bias

Randomization and masked clinical assessment strengthen comparison. Therapist allegiance/performance effects, possible contamination, unverified participant-role masking and follow-up attrition remain. No formal RoB or Jadad score assigned.

attrition

Assessment retention 154/172 post-shelter, 142/172 post-treatment, 135/172 at 6 months, 127/172 at 12 months. At 12 months 56/83 HOPE and 71/89 PCT+ contributed CAPS data. Treatment dropout 6/83 versus 5/89 is distinct from missing assessments. Black participants more often completed all assessments than White participants (81.6% vs 62.5%, p=.008).

confounding

ITT multivariate models use all available data under missing-at-random assumption; robust SEs and alpha<.01. Significant within-group change cannot separate psychotherapy, shelter services and time.

adverse Findings

Authors report no study-related serious adverse events, not zero adverse events overall. Ten participants were removed from assigned treatment for higher/different care: 6 HOPE, 4 PCT+; still invited to follow-up. Residual symptoms and some further abuse persisted.

transfer Limits

Women with recent IPV and diagnosed PTSD in US shelters; severe suicidal intent/plan, current psychosis, recent substance dependence, bipolar disorder or concurrent individual therapy were excluded.

jadad

not established

masking Roles

participants

Author calls trial double-blind and describes all treatment as HOPE for blinding, identical workbook naming with arm-specific content, and discouraging sharing. These are allocation-identity concealment procedures; the participant role is not separately explicitly confirmed and masking success is unmeasured.

providers

Therapists trained in and delivered both distinct protocols; provider masking is not supported.

assessors

Graduate psychology assessors explicitly masked to treatment condition at follow-up.

analysts

Not established from accessed full report.

population

relation

direct

population

Women residing in domestic-violence shelters with IPV-related PTSD.

exposure Evidence

At least one SVAW or PMWI IPV event in month before shelter entry and full DSM-IV-TR IPV-related PTSD by CAPS were required.

rationale

Explicit domestic/intimate-partner violence exposure in the studied population; psychological intervention is within Language scope.

transfer Limit

See limitation and quality fields; no population-wide clinical recommendation is implied.

status

unassessed

score

Not recorded

1. id

   ptsd

   evidence

   1. field

      title

      text

      A Randomized Controlled Trial Comparing HOPE Treatment and Present-Centered Therapy in Women Residing in Shelter with PTSD from Intimate Partner Violence.

      matched Text

      PTSD

   2. field

      population

      text

      Women residing in domestic-violence shelters with IPV-related PTSD.

      matched Text

      PTSD

   3. field

      outcomes

      text

      CAPS PTSD severity and IPV measures | Reliable PTSD improvement and diagnosis | Depression, empowerment, posttraumatic cognitions and health-related quality of life

      matched Text

      PTSD

   scope

   Study population or investigated outcome; not a diagnosis or efficacy claim.

2. id

   trauma

   evidence

   1. field

      outcomes

      text

      CAPS PTSD severity and IPV measures | Reliable PTSD improvement and diagnosis | Depression, empowerment, posttraumatic cognitions and health-related quality of life

      matched Text

      posttraumatic

   scope

   Study population or investigated outcome; not a diagnosis or efficacy claim.

3. id

   depression

   evidence

   1. field

      outcomes

      text

      CAPS PTSD severity and IPV measures | Reliable PTSD improvement and diagnosis | Depression, empowerment, posttraumatic cognitions and health-related quality of life

      matched Text

      Depression

   scope

   Study population or investigated outcome; not a diagnosis or efficacy claim.

ptsd · trauma · depression

2

status

not-indexed

retrieval Available

false